 Also, a U.S. Supreme Court decision involving OxyContin maker Purdue Pharma could cost Delaware $45 million. The U.S. Supreme Court rejecting a nationwide settlement that would have shielded members of the family who own the company from civil lawsuits over the toll of opioids, but also would have provided billions of dollars to combat the opioid epidemic.